COVID-19 and Cognitive Impairment: Severity, Evolution, and Functional Impact during Inpatient Rehabilitation

1. Introduction

Acute and critical illness frequently result in cognitive impairment, affecting function and quality of life¹. COVID-19 can result in respiratory distress, hypoxia, ICU admission, intubation/ventilation, delirium, and vascular complications, all associated with cognitive impairment². Cognitive deficits lead to dependence in activities of daily living³ (ADLs), prompting the need for assessing and treating cognitive dysfunction to optimize function.

Studies on COVID-19 show a high frequency of cognitive impairment in mild to severe disease expressions. Among community-dwelling patients with mild cases of COVID-19, 21% of patients experienced a decline in cognitive functioning⁴. 81% of hospitalized but post-acute COVID-19 patients score abnormally on neuropsychological measures of attention, processing speed, and executive function⁵. There is still limited knowledge on how cognitive deficits evolve and impact functional outcome. One study found 80% of COVID-19 patients on a rehabilitation unit had cognitive deficits, with continued impairment in over half of the patients at 1 month follow-up⁶; however, the relationship to functional gain was not evaluated. This study aims to determine the magnitude and change in cognitive impairment, correlates of cognitive impairment, and the relation between cognition and function, in a relatively large sample of COVID-19 patients admitted to inpatient rehabilitation.

2. Methods

94 patients hospitalized for COVID-19 were admitted to an inpatient rehabilitation unit (IRU) from March-August 2020. Seventeen patients were not administered our cognitive measure as they were either deemed as not exhibiting cognitive impairment during instrumental ADLs or underwent other cognitive testing, resulting in a final sample of 77. Patients were medically stable, able to tolerate 3 hours/day of therapy, and had potential to gain function. Infection control guidelines were followed, allowing for admission of positive COVID-19 patients and inperson administration of our cognitive measure. All data were extracted from retrospective chart reviews under approval of the Weill Cornell Medicine Institutional Review Board. 19/77 patients underwent a separate neuropsychological evaluation during their admission, the results of which have been published⁵; the results described here are novel.

Demographic/clinical data extracted included age, gender, prior level of function, intubation history and length, delirium history, and IRU and acute care lengths of stay (LOS) (Table 1). The Montreal Cognitive Assessment (MoCA) was administered by occupational therapists (OT) 72 hours before/after admission to the IRU. The minimal clinical important difference (MCID) of 3 points was used⁷. Scores range from 0-30 and are stratified as follows: ≥26=normal, 18-25=mild impairment, 11-17=moderate impairment, and ≤10=severe impairment⁸. Admission MoCA assessments were administered on all 77 subjects and discharge MoCA assessments on 45/77. Three patients received the Blind MoCA, which was converted to 30-point scale per established guidelines⁸. 32 patients did not receive discharge assessment as they either scored normal on the initial assessment, were unavailable, and/or declined.

The Quality Indicator for Self-Care (QI-SC) is a standard of care functional assessment for inpatient rehabilitation facilities. Items scored on a scale of 1 to 6 include eating, grooming, toileting, bathing, upper body dressing, lower body dressing, and donning/doffing footwear. Total score ranges from 7, indicating total assistance, to 42, indicating independence⁹. The QI-SC is reliable and discriminates between the quality of care among rehabilitation facilities⁹. OTs assigned admission and discharge QI-SC scores to all participants.

Statistical analyses used non-parametric tests to evaluate group differences (Mann-Whitney U), within-group change from admission to discharge (Wilcoxon Signed-Ranks Test), association between continuous variables (Spearman rank-order correlations), and chi-square tests for categorical variables. Effect sizes are reported as Cohen’s d.

3. Results

80.5% of patients demonstrated cognitive deficits on the MoCA at admission, of whom 15/77 were in the normal range, 39/77 had mild deficits, 20/77 had moderate deficits, and 3/77 had severe deficits (Figure 1). Admission MoCA scores were higher for patients who did not previously have delirium (M=22.03, SD=4.64) than patients who previously had delirium (M=18.95, SD=5.8), U=466.5, p=.02, Cohen’s d=.58. Admission MoCA did not differ based on whether a patient was intubated (U=454.5, p=.82), age (r_S=-.15, p=.19) or acute hospitalization length of stay (r_S=-.08 p=.50).

• Download figure
• Open in new tab

Figure 1.

Classification of cognitive impairment by score on the Montreal Cognitive Assessment (MoCA) at admission in the full sample, admission in the subsample with discharge scores, and discharge in the latter sample.

Patients with discharge MoCA scores (n=45) did not differ from those who were not administered the MoCA at discharge (n=32) in age, gender, prior neurologic history, prior delirium, prior intubation, or prior hypoxia (all p’s>.05). These 45 patients with admission and discharge MoCA scores improved on the MoCA (M=4.02, SD=3.67, Z=5.08, p<.001, Cohen’s d=1.10) and QI-SC (M=12.2, SD=6.18, Z=5.47, p<.001, Cohen’s d=1.97). 32/45 patients improved and met the MoCA MCID at discharge. This group of patients had a greater increase in QI-SC scores (M=13.88, SD=5.01) versus patients who did not meet the MCID or declined (M=9.46, SD=7.79), Mann-Whitney U=113.0, p=.02, Cohen’s d=0.75, a relationship that persisted in a linear regression model accounting for age and delirium. Despite overall improvement, 28/45 patients still had mild deficits on the MoCA at discharge, 7 had moderate deficits, none had severe deficits, and 10 scored in the normal range.

4. Discussion

Among 77 COVID-19 patients undergoing acute inpatient rehabilitation, 80.5% of patients demonstrated cognitive impairment, the majority of whom had mild deficits. This number is consistent with studies using neuropsychological assessments to evaluate cognition in hospitalized COVID-19 patients^5-6 and expands on these findings with a larger sample than previous studies. Consistent with the literature, delirium during acute hospitalization is associated with greater cognitive impairment at admission¹⁰, emphasizing the importance of early detection and management of delirium in COVID-19. The lack of association between admission cognitive impairment and intubation is also consistent with prior work.⁵

COVID-19 patients exhibited significant improvement in cognition with a large effect size. 32/45 (71.1%) percent exhibited clinically meaningful improvement, possibly reflecting natural recovery, improvement in residual acute mental status changes, and/or rehabilitation intervention effects. Mean QI-SC scores for this subgroup improved with a large effect size, signifying that patients required less assistance for basic ADLs. Notably, significantly greater functional improvement was seen in patients who exhibited a clinically meaningful improvement in cognition than those that did not. Cognitive ability is associated with short- and long-term independence with self-care tasks in older adults³ and our results reinforce the importance of targeting cognition to improve functional gains in COVID-19. COVID-19 patients warrant further follow-up as a majority continued to demonstrate mild deficits at discharge.

5. Conclusion

This study confirms the presence of cognitive impairment in COVID-19 patients with prolonged hospitalization requiring inpatient rehabilitation and provides new insights into the evolution of cognitive status. As most patients demonstrated mild/moderate cognitive deficits on admission, routine cognitive screening should be conducted for COVID-19 patients. Despite improvement during inpatient rehabilitation, a majority demonstrated mild cognitive deficits at discharge, indicating ongoing cognitive needs. As cognitive improvement is associated with functional gain, interventions targeting cognitive dysfunction in the acute inpatient rehabilitation setting may be important in optimizing independence.